# Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

> **NCT02072356** · EARLY_PHASE1 · COMPLETED · sponsor: **Ohio State University Comprehensive Cancer Center** · enrollment: 290 (actual)

## Conditions studied

- Adult Primary Hepatocellular Carcinoma
- Advanced Adult Primary Liver Cancer
- Localized Unresectable Adult Primary Liver Cancer
- Recurrent Adult Primary Liver Cancer

## Interventions

- **RADIATION:** yttrium Y 90 glass microspheres
- **OTHER:** laboratory biomarker analysis
- **DRUG:** TheraSphere

## Key facts

- **NCT ID:** NCT02072356
- **Lead sponsor:** Ohio State University Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-11
- **Primary completion:** 2021-06-15
- **Final completion:** 2021-06-15
- **Target enrollment:** 290 (ACTUAL)
- **Last updated:** 2022-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02072356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02072356, "Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02072356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*